Omnaris

Active Ingredient(s): Ciclesonide
FDA Approved: * October 20, 2006
Pharm Company: * ALTANA PHARMA
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Omnaris Overview

Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, Zetonna, and Alvesco[1] for hay fever in the US and Canada. Side effects of the medication include headache, nosebleeds, and inflammation of the nose and throat linings.[2] It was patented in 1990 and approved for medical use in 2005.[3] The drug was approved for adults and children 12 and o...

Read more Omnaris Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ciclesonide

Recent Omnaris Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ciclesonide
  • Aerosol: 74mcg
  • Aerosol, Metered: 0.037mg/inh, 0.08mg/inh, 0.16mg/inh, 80mcg
  • Spray: 50mcg
  • Spray, Metered: 0.05mg/inh
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Omnaris: (4 results)

Sorted by National Drug Code
  • 52125-669 Omnaris 50 ug/1 Nasal Spray by Remedyrepack Inc.
  • 54868-6020 Omnaris 50 ug/1 Nasal Spray by Physicians Total Care, Inc.
  • 63402-701 Omnaris 50 ug/1 Nasal Spray by Sunovion Pharmaceuticals Inc.
  • 70515-701 Omnaris 50 ug/1 Nasal Spray by Covis Pharma

Other drugs which contain Ciclesonide or a similar ingredient: (3 results)

Related Omnaris Topics:

OMNARIS (ciclesonide) Nasal Spray for Nasal Allergy Relief
OMNARIS is for the treatment of nasal symptoms (sneezing, runny nose, itchy nose, and stuffy nose) associated with seaso...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA